FDA Releases Draft Guidance on Open Public Hearing for Advisory Committee Meetings

Summary

The Food and Drug Administration (FDA) has released a draft guidance document outlining the procedures for public participation in FDA advisory committee meetings, specifically the open public hearing (OPH) sessions.